DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Fight against Hepatitis C takes a beating

Karam Prakash Tribune News Service Patiala, July 11 The Covid-19 pandemic has adversely impacted the government’s battle against Hepatitis C – commonly known as ‘Kala Pilia’ – in the state, reveals the data. If left untreated, Hepatitis C can lead...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Karam Prakash

Advertisement

Tribune News Service

Patiala, July 11

Advertisement

The Covid-19 pandemic has adversely impacted the government’s battle against Hepatitis C – commonly known as ‘Kala Pilia’ – in the state, reveals the data.

If left untreated, Hepatitis C can lead to cirrhosis or liver cancer, say the experts.

Advertisement

Government Rajindra Hospital, one of the two model treatment centres in the state for Hepatitis C, saw a considerable decline in the cases. From 765 in 2019, the cases dipped to 428 in 2020. So far in 2021, the count is only 249.

Notably, Government Rajindra Hospital caters to the entire Malwa belt, which has around 60 per cent of the total Hepatitis cases reported in Punjab.

Similarly, at Government Mata Kaushalya Hospital here, the disruption in OPD services due to Covid has already resulted in a steep dip in the reporting of Hepatitis C patients.

As per the diagnostic count, the number of Hepatitis C patients have come down from 369 in 2019 to 222 in 2020. This year, only 101 patients have reported at the hospital so far.

Dr Divjot Singh, district epidemiologist, said the decline in footfall of Hepatitis C patients was due to Covid.

The OPD services had to be shut for months due to Covid, said Dr Singh, adding “though the government is providing free treatment for Hepatitis C, including tests, patients seemingly fearing Covid infection are not showing up for the treatment”.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Classifieds tlbr_img3 Premium tlbr_img4 Videos tlbr_img5 E-Paper